Insys Therapeutics, Inc. EBITDA 2013-2019 | INSYQ
Insys Therapeutics, Inc. ebitda from 2013 to 2019. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Insys Therapeutics, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2018 | $-120 |
| 2017 | $-211 |
| 2016 | $16 |
| 2015 | $97 |
| 2014 | $64 |
| 2013 | $34 |
| 2012 | $-22 |
| 2011 | $-16 |
| Insys Therapeutics, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2019-03-31 | $-120 |
| 2018-12-31 | $-47 |
| 2018-09-30 | $-29 |
| 2018-06-30 | $-26 |
| 2018-03-31 | $-18 |
| 2017-12-31 | $-19 |
| 2017-09-30 | $-174 |
| 2017-06-30 | $-8 |
| 2017-03-31 | $-10 |
| 2016-12-31 | $-1 |
| 2016-09-30 | $4 |
| 2016-06-30 | $8 |
| 2016-03-31 | $4 |
| 2015-12-31 | $33 |
| 2015-09-30 | $38 |
| 2015-06-30 | $16 |
| 2015-03-31 | $10 |
| 2014-12-31 | $14 |
| 2014-09-30 | $21 |
| 2014-06-30 | $16 |
| 2014-03-31 | $13 |
| 2013-12-31 | $15 |
| 2013-09-30 | $13 |
| 2013-06-30 | $6 |
| 2013-03-31 | $1 |
| 2012-12-31 | $-8 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-5 |
| 2012-03-31 | $-6 |
